Selected Parameters of Bone Turnover in Neuroendocrine Tumors-A Potential Clinical Use?

Janusz StrzelczykMonika Wójcik-GiertugaJoanna Katarzyna StrzelczykAlicja Prawdzic SeńkowskaKrzysztof BiernackiBeata Kos-Kudła

Published in: Journal of clinical medicine (2023)

Markers of bone turnover cannot be used in the routine diagnostics of neuroendocrine tumors. Nonetheless, these markers may help evaluate the skeletal system in patients with NETs. Further research is needed to determine the utility of osteocalcin (OST) and osteoprotegerin (OPG) as potential biomarkers for neuroendocrine tumors.

Keyphrases

neuroendocrine tumors
bone mineral density
postmenopausal women
body composition
soft tissue
bone loss
bone regeneration
clinical practice
nuclear factor
immune response
inflammatory response
toll like receptor